|
C9ORF5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.4262592762957E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.78621570259929E-12 |
| Normal-vs-Stage2 |
5.842400E-03 |
| Normal-vs-Stage3 |
2.915500E-03 |
| Normal-vs-Stage4 |
8.217800E-02 |
| Stage1-vs-Stage2 |
4.801800E-01 |
| Stage1-vs-Stage3 |
6.807600E-01 |
| Stage1-vs-Stage4 |
7.528800E-01 |
| Stage2-vs-Stage3 |
8.733200E-01 |
| Stage2-vs-Stage4 |
8.878000E-01 |
| Stage3-vs-Stage4 |
9.871600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.51740858661742E-12 |
| Normal-vs-AfricanAmerican |
1.63860000013116E-07 |
| Normal-vs-Asian |
6.76380000008692E-07 |
| Caucasian-vs-AfricanAmerican |
6.748200E-01 |
| Caucasian-vs-Asian |
3.538200E-01 |
| AfricanAmerican-vs-Asian |
2.596400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65767399806782E-12 |
| Normal-vs-Female |
7.562100E-04 |
| Male-vs-Female |
1.657930E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.14300000020329E-07 |
| Normal-vs-Extreme_Weight |
3.13082892944294E-13 |
| Normal-vs-Obese |
1.785630E-04 |
| Normal-vs-Extreme_Obese |
3.75959999798781E-08 |
| Normal_Weight-vs-Extreme_Weight |
5.919200E-01 |
| Normal_Weight-vs-Obese |
1.594600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.093000E-01 |
| Extreme_Weight-vs-Obese |
2.756400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.821600E-01 |
| Obese-vs-Extreme_Obese |
4.412100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.924770E-01 |
| Normal-vs-Age(41-60Yrs) |
1.15670000000456E-06 |
| Normal-vs-Age(61-80Yrs) |
8.88178419700125E-16 |
| Normal-vs-Age(81-100Yrs) |
1.01110000039206E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.375200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.063370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.465820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.183700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.776400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.370200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.58900012539698E-10 |
| Normal-VS-Type2 PRCC |
1.62458935193399E-12 |
| Normal-VS-KIRP CIMP |
3.322400E-01 |
| Normal-VS-Unclassified PRCC |
3.586900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.198000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.812100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.648200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.475300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.424400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.503400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.63340501919174E-11 |
| Normal-vs-N1 |
3.760400E-04 |
| Normal-vs-N2 |
8.866400E-01 |
| N0-vs-N1 |
2.568800E-01 |
| N0-vs-N2 |
4.395800E-01 |
| N1-vs-N2 |
5.682600E-01 |
|
|
